Operated by Ieldas Inc. · Independent methodology · Affiliate-supported. Read our ownership & funding disclosure and how every figure is verified.
GLP1ProviderFinderUS price records
HomeBlog › The GLP-1 Prior Authorization, Done Right the First Time

Journal · Updated 2026-08-11

The GLP-1 Prior Authorization, Done Right the First Time

By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify

The short answer

A prior authorization is a documentation exam, and most failures are incomplete homework rather than true non-coverage. The package that passes, assembled before submission: the diagnosis, coded correctly (obesity with BMI documented in the chart — current and historical readings; or the indication door being used: T2D with A1c, cardiovascular disease with event history, OSA with the sleep study); comorbidities on the record (hypertension, dyslipidemia, prediabetes — each one both strengthens medical necessity and may lower the BMI threshold plans require); step-therapy evidence where demanded (documented lifestyle-program participation, prior weight-management attempts, or previously tried medications, with dates); and the plan's own criteria, read first — every insurer publishes its GLP-1 PA policy, and writing the request to its checklist converts a coin-flip into a formality. Timeline: standard PAs resolve in days-to-two-weeks; expedited pathways exist for urgent clinical cases; and silence past the deadline is a follow-up call, not a verdict.

The choreography, and the failure modes

The PA is a three-party dance — you, the prescriber's office, the plan — and it stalls wherever a party assumes another is moving. Your moves: request the PA explicitly (offices don't always initiate), supply the history the chart lacks (old weights, prior program receipts, outside records), confirm submission happened and get the reference number, and calendar the decision deadline. The office's moves: matching the request to the plan's published criteria verbatim, attaching the records rather than citing them, and using peer-to-peer review when the plan offers it — a prescriber-to-plan-physician call that resolves many borderline cases. The failure modes to pre-empt: the diagnosis coded as something adjacent (a "weight management counseling" code where the plan wants the obesity diagnosis), BMI in the notes but not the problem list, step-therapy attempts real but undocumented, and the quiet killer — a PA approved for a drug the formulary tiers expensively, which is why the criteria-read includes the tier and the preferred-agent list before the fight begins. A denial is the start of the appeal process, not the end of the answer — and a large share of properly appealed denials overturn, which is the statistic that should power the whole enterprise.

Questions people ask

What do insurance companies require for GLP-1 prior authorization?

The published criteria vary by plan but cluster: documented BMI (≥30, or ≥27 with comorbidities — thresholds vary), the qualifying diagnosis correctly coded, comorbidity records, and often step-therapy evidence (lifestyle programs or prior medications, with dates). Read your plan's own PA policy first and build the request to its checklist.

How long does a GLP-1 prior authorization take?

Typically days to two weeks for standard review, faster on expedited pathways for urgent cases. Get the submission reference number, calendar the plan's decision deadline, and treat silence past it as a follow-up call — stalled PAs die of neglect more than denial.

Why was my GLP-1 prior authorization denied?

Usually documentation, not destiny: BMI absent from the problem list, step-therapy attempts undocumented, the diagnosis coded adjacent to what the policy requires, or the request written without reading the plan's criteria. Fix the gap and appeal — a large share of properly appealed denials overturn.

This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.